ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy genomics vaccine science policy

Biden Names Geneticist Eric Lander as Top Science Adviser
Max Kozlov | Jan 18, 2021 | 3 min read
If confirmed, Lander will head the Office of Science and Technology Policy, a position that President Donald Trump left vacant for 18 months at the beginning of his term.
Opinion: The Politics of Science and Racism
Sadye Paez and Erich D. Jarvis | Aug 18, 2020 | 7 min read
Race has been used to segment humanity and, by extension, establish and enforce a hierarchy in science. Individual and institutional commitments to racial justice in the sciences must involve political activity.
Controversy Mounts Over Gene Patenting Policy
Scott Veggeberg | Apr 26, 1992 | 5 min read
Scientists in industry and academia foresee trouble as NIH persists in claiming ownership over partial sequences Date: April 27, 1992 The reviews from the scientific community remain mostly negative over the National Institutes of Health's patent application for a total of 2,722 partial human gene sequences. Academic researchers, who say they are mostly unaffected by the patenting process, nevertheless are appalled; and while some in the commercial sector of the biotech community now believe
Illustration of scientists
Opinion: How Large International Collaborations Have Fared in the Pandemic
Sadye Paez, Giulio Formenti, and Erich D. Jarvis | May 2, 2022 | 5 min read
COVID-19 has challenged the progress of Big Science. Here are the lessons learned.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Opinion: Ethical Boundaries Needed on the Uses of Synthetic DNA
John D. Loike and Robert Pollack | Mar 1, 2019 | 4 min read
A newly expanded genetic alphabet that includes four synthetic nucleotides highlights the need for strict boundaries on their use.
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
masked teacher sitting on floor showing masked students something on a tablet
Does Science Support Lifting School Mask Mandates?
Rachael Moeller Gorman | Feb 28, 2022 | 10+ min read
The CDC has given the OK to lift indoor mask mandates in much of the US, and a growing number of states no longer require face coverings in schools. But most experts agree that masks slow school spread of SARS-CoV-2, and whether now is the right time to allow teachers and students to unmask is a matter of debate.
The Ethical Use of Unpublished DNA Sequences
Richard Hyman(rhyman@stanford.edu) | Dec 19, 2004 | 3 min read
By long-standing policy, scientific data are not public until a reviewed manuscript is published.
Sequencing Stakes: Celera Genomics Carves Its Niche
Ricki Lewis | Jul 18, 1999 | 8 min read
J. Craig Venter is no stranger to contradiction and controversy. He seems to thrive on it. In 1991, when the National Institutes of Health was haggling over patenting expressed sequence tags (ESTs)--a shortcut to identifying protein-encoding genes--Venter the inventor accepted a private offer to found The Institute for Genomic Research (TIGR) in Rockville, Md. TIGR would discover ESTs and give most of them to a commercial sibling, Human Genome Sciences (HGS), to market. ESTs are now a standard

Run a Search

ADVERTISEMENT